Role of Acupuncture in the Treatment or Prevention of Migraine, Tension-Type Headache, or Chronic Headache Disorders

This comprehensive review examines current scientific evidence on the efficacy of acupuncture in the treatment and prevention of headache disorders, including migraine, tension-type headache, and chronic headaches. The study synthesizes findings from Cochrane systematic reviews and individual patient data meta-analyses, representing one of the most robust analyses available on this topic. For migraine, the researchers analyzed 22 randomized controlled trials involving 4,985 participants, with acupuncture interventions lasting at least 8 weeks. Comparisons included acupuncture versus routine care, sham acupuncture, and established prophylactic medications such as metoprolol and flunarizine.

The results demonstrated that acupuncture was statistically superior to routine care and to drug treatment at 2 months post-randomization both in headache frequency and in clinical response (reduction of at least 50% in frequency). Acupuncture also showed advantages over sham acupuncture, although with statistical heterogeneity across studies. For tension-type headache, the analysis included 12 studies with 2,349 patients. Acupuncture demonstrated statistically significant superiority over routine care and sham acupuncture at multiple follow-up periods (2, 3-4, and 5-6 months), both for clinical response and for reduction in the number of headache days.

A particularly important individual patient data meta-analysis, conducted by Vickers and colleagues, analyzed 29 randomized controlled trials covering several chronic pain conditions, including headache. This study demonstrated a statistically significant effect size for acupuncture compared to sham acupuncture (coefficient 0.38; 95% CI: 0.22-0.55), providing robust evidence that the effects of acupuncture transcend placebo effects. Additional studies not included in the main reviews also contribute to the evidence, showing superiority of acupuncture over sham acupuncture for acute migraine attacks and equivalence or superiority to topiramate in the prophylaxis of chronic migraine. Cost-effectiveness analyses conducted in the United Kingdom and Germany suggest that acupuncture represents a cost-effective therapeutic option in these countries, although similar data for the United States are limited.

The authors acknowledge important limitations, including heterogeneity in the definition and reporting of outcomes across studies, and the unresolved question of the contribution of placebo effects to the observed clinical efficacy. However, the evidence is consistent in demonstrating significant clinical benefits of acupuncture as an adjunct to usual care. The clinical implications are substantial, suggesting that acupuncture should be considered a valid therapeutic option for patients with migraine requiring prophylactic treatment, particularly those who refuse prophylactic medications or experience adverse effects. For tension-type headache, acupuncture emerges as an option for frequent episodes or chronic tension-type headache.